Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 13/20 | 0.57 |
| ▸ | CTRB1 | P17538 | 6/20 | 0.57 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6634622 | 0.93 | CTRB1 (0.56) | ELANECTRB1 | |
| SCHEMBL6722619 | 0.93 | ELANE (0.59) | ELANECTRB1TDP2EGFRERBB2 | |
| SCHEMBL6636032 | 0.88 | CTRB1 (0.59) | ELANECTRB1 | |
| SCHEMBL6636501 | 0.87 | CTRB1 (0.58) | ELANECTRB1 | |
| SCHEMBL6638458 | 0.87 | ELANE (0.54) | ELANECTRB1TDP2 | |
| SCHEMBL6639608 | 0.86 | CTRB1 (0.53) | ELANECTRB1TDP2EGFRERBB2 | |
| SCHEMBL6639306 | 0.86 | ELANE (0.60) | ELANECTRB1TDP2 | |
| SCHEMBL6637600 | 0.86 | ELANE (0.57) | ELANECTRB1 | |
| SCHEMBL6638450 | 0.84 | CTRB1 (0.55) | ELANECTRB1 | |
| SCHEMBL6641652 | 0.83 | CTRB1 (0.57) | ELANECTRB1TDP2EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | claimed |
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |